Matthias D'Hooghe

Title: Matthias D'Hooghe: Innovator in HDAC6 Inhibitors

Introduction

Matthias D'Hooghe is a notable inventor based in Evergem, Belgium. He has made significant contributions to the field of biomedical research, particularly in the development of selective HDAC6 inhibitors. With a total of 2 patents, his work focuses on innovative treatments for various diseases.

Latest Patents

D'Hooghe's latest patents include "Selective HDAC6 inhibitors and uses thereof" and "HDAC6 inhibitors and uses thereof." The first patent relates to selective Histone deacetylase 6 (HDAC6) inhibitors and compositions containing these compounds. It outlines methods for treating diseases where inhibition of HDAC6 is beneficial, such as cell proliferative diseases, autoimmune or inflammatory disorders, and neurodegenerative diseases. The second patent also addresses HDAC6 inhibitors and their applications in treating similar conditions, including viral diseases and malaria.

Career Highlights

Matthias D'Hooghe is affiliated with the University of Ghent, where he conducts his research and development work. His innovative approach to HDAC6 inhibitors has positioned him as a key figure in the field of therapeutic research.

Collaborations

D'Hooghe collaborates with esteemed colleagues such as Rob De Vreese and Marc Bracke, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Matthias D'Hooghe's work in developing HDAC6 inhibitors represents a significant advancement in the treatment of various diseases. His contributions to biomedical research continue to pave the way for new therapeutic options.